Workflow
Investor scrutiny
icon
搜索文档
PetMed Express (PETS) Faces Investor Scrutiny Amid Filing Delays, Executive Departures, Admitted Accounting Rule Violations -- Hagens Berman
Globenewswire· 2025-10-10 06:58
SAN FRANCISCO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Investors in PetMed Express (NASDAQ: PETS) have seen the price of their shares steadily decline by about 26% since June 16, 2025, when the company announced it would not timely file its annual financial statements for its year ended March 31, 2025. Later disclosures reveal serious additional company problems. The developments and severe market reaction have prompted national shareholders rights firm Hagens Berman to open an investigation into whether PetMed m ...